Multidrug resistance 1 gene in inflammatory bowel disease: A meta-analysis

Table 4 Summary of ORs and 95% CIs for different outcomes obtained at the meta-analysis

		Fixed effects		Random effects		Heterogeneity test
		P value	OR (95% CI)	P value	OR (95% CI)
C3435T	Outcome CD T vs C (6 studies)	0.519	0.968 (0.878-1.068)	0.722	0.974 (0.842-1.126)	0.09
	TT vs CC (5 studies)	0.297	0.892 (0.720-1.106)	0.472	0.900 (0.675-1.200)	NS
G2677T/A	G vs T (4 studies)	0.635	1.027 (0.920-1.145)	0.635	1.027 (0.920-1.145)	NS
	GG vs GT TT (3 studies) Outcome UC	0.338	1.092 (0.912-1.308)	0.338	1.092 (0.912-1.308)	NS
C3435T	T vs C (6 studies)	0.002	1.170 (1.062-1.289)	0.003	1.178 (1.058-1.311)	NS
	TT vs CC (5 studies)	0.008	1.332 (1.080-1.644)	0.017	1.367 (1.057-1.768)	NS
G2677T/A	G vs T (4 studies)	0.843	0.989 (0.887-1.103)	0.862	0.986 (0.836-1.162)	NS
	GG vs GT TT (3 studies) Outcome IBD	0.947	0.994 (0.830-1.190)	0.947	0.994 (0.830-1.190)	NS
C3435T	T vs C (6 studies)	0.083	1.074 (0.991-1.165)	0.135	1.083 (0.976-1.201)	NS
	TT vs CC (5 studies)	0.225	1.116 (0.935-1.332)	0.274	1.135 (0.904-1.426)	NS
G2677T/A	G vs T (5 studies)	0.351	1.041 (0.957-1.132)	0.448	1.047 (0.930-1.178)	NS
	GG vs GT TT (4 studies)	0.366	1.065 (0.929-1.221)	0.366	1.065 (0.929-1.221)	NS